182 related articles for article (PubMed ID: 29515226)
1. Finding the right treatment for neonatal abstinence syndrome: is this the right time?
Yen E; Davis JM
J Perinatol; 2018 Jul; 38(7):785-787. PubMed ID: 29515226
[TBL] [Abstract][Full Text] [Related]
2. Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome.
Kraft WK; Adeniyi-Jones SC; Chervoneva I; Greenspan JS; Abatemarco D; Kaltenbach K; Ehrlich ME
N Engl J Med; 2017 Jun; 376(24):2341-2348. PubMed ID: 28468518
[TBL] [Abstract][Full Text] [Related]
3. The relationship between gestational age and the severity of neonatal abstinence syndrome.
Gibson KS; Stark S; Kumar D; Bailit JL
Addiction; 2017 Apr; 112(4):711-716. PubMed ID: 27886650
[TBL] [Abstract][Full Text] [Related]
4. Revised dose schema of sublingual buprenorphine in the treatment of the neonatal opioid abstinence syndrome.
Kraft WK; Dysart K; Greenspan JS; Gibson E; Kaltenbach K; Ehrlich ME
Addiction; 2011 Mar; 106(3):574-80. PubMed ID: 20925688
[TBL] [Abstract][Full Text] [Related]
5. Management of neonatal abstinence syndrome in neonates born to opioid maintained women.
Ebner N; Rohrmeister K; Winklbaur B; Baewert A; Jagsch R; Peternell A; Thau K; Fischer G
Drug Alcohol Depend; 2007 Mar; 87(2-3):131-8. PubMed ID: 17000060
[TBL] [Abstract][Full Text] [Related]
6. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
[TBL] [Abstract][Full Text] [Related]
7. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome.
Jones HE; Johnson RE; Jasinski DR; O'Grady KE; Chisholm CA; Choo RE; Crocetti M; Dudas R; Harrow C; Huestis MA; Jansson LM; Lantz M; Lester BM; Milio L
Drug Alcohol Depend; 2005 Jul; 79(1):1-10. PubMed ID: 15943939
[TBL] [Abstract][Full Text] [Related]
8. Does Maternal Buprenorphine Dose Affect Severity or Incidence of Neonatal Abstinence Syndrome?
Wong J; Saver B; Scanlan JM; Gianutsos LP; Bhakta Y; Walsh J; Plawman A; Sapienza D; Rudolf V
J Addict Med; 2018; 12(6):435-441. PubMed ID: 29905586
[TBL] [Abstract][Full Text] [Related]
9. Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.
Kanervo M; Tupola S; Nikkola E; Rantakari K; Kahila H
Eur J Obstet Gynecol Reprod Biol; 2024 Jun; 297():106-110. PubMed ID: 38608352
[TBL] [Abstract][Full Text] [Related]
10. Neonatal Abstinence Syndrome Severity Index Predicts 18-Month Neurodevelopmental Outcome in Neonates Randomized to Morphine or Methadone.
Flannery T; Davis JM; Czynski AJ; Dansereau LM; Oliveira EL; Camardo SA; Lester BM
J Pediatr; 2020 Dec; 227():101-107.e1. PubMed ID: 32805259
[TBL] [Abstract][Full Text] [Related]
11. Buprenorphine + naloxone in the treatment of opioid dependence during pregnancy-initial patient care and outcome data.
Debelak K; Morrone WR; O'Grady KE; Jones HE
Am J Addict; 2013; 22(3):252-4. PubMed ID: 23617867
[TBL] [Abstract][Full Text] [Related]
12. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
[TBL] [Abstract][Full Text] [Related]
13. [Drug withdrawal in newborns - clinical data of 49 infants with intrauterine drug exposure: what should be done?].
Bläser A; Pulzer F; Knüpfer M; Robel-Tillig E; Vogtmann C; Nickel P; Kiess W
Klin Padiatr; 2008; 220(5):308-15. PubMed ID: 18260044
[TBL] [Abstract][Full Text] [Related]
14. Breastfeeding promotion for management of neonatal abstinence syndrome.
Pritham UA
J Obstet Gynecol Neonatal Nurs; 2013; 42(5):517-26. PubMed ID: 24020477
[TBL] [Abstract][Full Text] [Related]
15. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
[TBL] [Abstract][Full Text] [Related]
16. Retrospective chart review comparing morphine and methadone in neonates treated for neonatal abstinence syndrome.
Young ME; Hager SJ; Spurlock D
Am J Health Syst Pharm; 2015 Dec; 72(23 Suppl 3):S162-7. PubMed ID: 26582303
[TBL] [Abstract][Full Text] [Related]
17. Hospital morphine preparation for abstinence syndrome in newborns exposed to buprenorphine or methadone.
Colombini N; Elias R; Busuttil M; Dubuc M; Einaudi MA; Bues-Charbit M
Pharm World Sci; 2008 Jun; 30(3):227-34. PubMed ID: 18008179
[TBL] [Abstract][Full Text] [Related]
18. Morphine vs Methadone Treatment for Infants with Neonatal Abstinence Syndrome.
Tolia VN; Murthy K; Bennett MM; Greenberg RG; Benjamin DK; Smith PB; Clark RH
J Pediatr; 2018 Dec; 203():185-189. PubMed ID: 30220442
[TBL] [Abstract][Full Text] [Related]
19. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
[TBL] [Abstract][Full Text] [Related]
20. Perinatal outcomes of Australian buprenorphine-exposed mothers and their newborn infants.
Patel P; Abdel-Latif ME; Hazelton B; Wodak A; Chen J; Emsley F; Feller JM; Lui K; Oei JL
J Paediatr Child Health; 2013 Sep; 49(9):746-53. PubMed ID: 23745982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
